Abstract
Carbamazepine is a therapeutic anticonvulsant, used to manage pain. We often use it to treat trigeminal and post-herpes zoster neuralgias. Interstitial pneumonitis (IP) is a known adverse consequence of using carbamazepine, with bronchiolitis obliterans and organizing pneumonitis. (BOOP) drug-induced IP as typical examples. Here we described a patient with post-herpes zoster neuralgia, who suffered from drug-induced acute IP that differed from cases typically induced by carbamazepine.
Keywords: Carbamazepine, drug-induced interstitial pneumonitis
Current Drug Safety
Title: An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine
Volume: 4 Issue: 1
Author(s): Hideyuki Narita, Takuro Ozawa, Takahisa Nishiyama, Shohei Matsumoto, Seigo Watanabe and Atsushi Isshiki
Affiliation:
Keywords: Carbamazepine, drug-induced interstitial pneumonitis
Abstract: Carbamazepine is a therapeutic anticonvulsant, used to manage pain. We often use it to treat trigeminal and post-herpes zoster neuralgias. Interstitial pneumonitis (IP) is a known adverse consequence of using carbamazepine, with bronchiolitis obliterans and organizing pneumonitis. (BOOP) drug-induced IP as typical examples. Here we described a patient with post-herpes zoster neuralgia, who suffered from drug-induced acute IP that differed from cases typically induced by carbamazepine.
Export Options
About this article
Cite this article as:
Narita Hideyuki, Ozawa Takuro, Nishiyama Takahisa, Matsumoto Shohei, Watanabe Seigo and Isshiki Atsushi, An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine, Current Drug Safety 2009; 4 (1) . https://dx.doi.org/10.2174/157488609787354486
DOI https://dx.doi.org/10.2174/157488609787354486 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Inhibitors of Nitric Oxide in Animal Models and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Molecular Docking for Identification of Potential Targets for Drug Repurposing
Current Topics in Medicinal Chemistry New Gene Therapy Strategies for Cancer Treatment: A Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Drug Interactions with Normal and TEN Epidermal Keratinocytes
Current Drug Safety Chemokine Receptor-directed Agents as Novel Anti-HIV-1 Therapies
Current Topics in Medicinal Chemistry Damnacanthal: A Promising Compound as a Medicinal Anthraquinone
Anti-Cancer Agents in Medicinal Chemistry Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome
Current Pharmaceutical Design Plasmid-Based Expression Technology Using Growth Hormone Releasing Hormone: A Novel Method for Physiologically Stimulating Long-Term Growth Hormone Secretion
Combinatorial Chemistry & High Throughput Screening The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients
Current Drug Discovery Technologies Pharmacogenomics of Open-Angle Glaucoma
Current Pharmacogenomics and Personalized Medicine Endogeneous Remyelination: Findings in Human Studies
CNS & Neurological Disorders - Drug Targets Synthesis of Eicosapentaenoic Acid-enriched Phosphatidylcholine and its Effect on Pro-inflammatory Cytokine Expression
Combinatorial Chemistry & High Throughput Screening Is Biotechnological Next-Generation Therapeutics Promising Enough in Clinical Development to Treat Advanced Colon Cancer?
Current Pharmaceutical Biotechnology Developments in High-Yield System Expressed Vaccines and Immunotherapy
Recent Patents on Biotechnology The Potential Mechanism of N-acetylcysteine in Treating COVID-19
Current Pharmaceutical Biotechnology Chemokines and Breast Cancer: A Gateway to Revolutionary Targeted Cancer Treatments?
Current Medicinal Chemistry Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based “Triple Therapy” Experience in Southern Italy
Reviews on Recent Clinical Trials Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Cardiac and Renal Nitric Oxide in the Adaptation to Hypovolemic Shock
Current Enzyme Inhibition Periarticular Corticosteroid Treatment of the Sacroiliac Joint
Current Rheumatology Reviews